These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15493275)

  • 1. Immunological studies of NK cell-deficient beige mice. II. Analysis of T-lymphocyte functions in beige mice.
    Baca ME; Mowat AM; Parrott DM
    Immunology; 1989 Jan; 66(1):131-7. PubMed ID: 15493275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological studies of NK cell-deficient beige mice. I. Defective ability of beige lymphocytes to mediate local and systemic graft-versus-host reactions.
    Baca ME; Mowat AM
    Immunology; 1989 Jan; 66(1):125-30. PubMed ID: 15493274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression.
    Kubota E; Ishikawa H; Saito K
    J Immunol; 1983 Sep; 131(3):1142-8. PubMed ID: 6604089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic control of in vitro NK-activity and in vivo resistance to tumors.
    Kärre K; Klein GO; Kiessling R; Klein G
    Tokai J Exp Clin Med; 1983 Dec; 8(5-6):429-48. PubMed ID: 6681339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of specific immune responses by feeding protein antigens. V. Induction of the tolerant state in the absence of specific suppressor T cells.
    Hanson DG; Miller SD
    J Immunol; 1982 May; 128(5):2378-81. PubMed ID: 6460822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective elicitation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice.
    Askenase PW; Van Loveren H; Kraeuter-Kops S; Ron Y; Meade R; Theoharides TC; Nordlund JJ; Scovern H; Gerhson MD; Ptak W
    J Immunol; 1983 Dec; 131(6):2687-94. PubMed ID: 6605986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vivo metastasis of human tumor transplant in T and NK cell immune-deficient mice].
    Wu BQ; Fang WG; Zheng J; Sun YK; Wang JL; Zhao XS; Yang JS; Lu CP; Sun J; Xu QM
    Zhonghua Zhong Liu Za Zhi; 1988 Jan; 10(1):1-3. PubMed ID: 3262047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The beige mutation in the mouse. II. Selectivity of the natural killer (NK) cell defect.
    Roder JC; Lohmann-Matthes ML; Domzig W; Wigzell H
    J Immunol; 1979 Nov; 123(5):2174-81. PubMed ID: 158612
    [No Abstract]   [Full Text] [Related]  

  • 9. Impaired immune responses toward alloantigens and tumor cells but normal thymic selection in mice deficient in the beta2 integrin leukocyte function-associated antigen-1.
    Shier P; Otulakowski G; Ngo K; Panakos J; Chourmouzis E; Christjansen L; Lau CY; Fung-Leung WP
    J Immunol; 1996 Dec; 157(12):5375-86. PubMed ID: 8955185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periplocoside E, an effective compound from Periploca sepium Bge, inhibited T cell activation in vitro and in vivo.
    Zhu YN; Zhao WM; Yang YF; Liu QF; Zhou Y; Tian J; Ni J; Fu YF; Zhong XG; Tang W; Zhou R; He PL; Li XY; Zuo JP
    J Pharmacol Exp Ther; 2006 Feb; 316(2):662-9. PubMed ID: 16204471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells.
    Chattopadhyay S; O'Rourke J; Cone RE
    Int Immunol; 2008 Apr; 20(4):509-16. PubMed ID: 18359787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of natural killer cells in the development of herpes simplex virus type 1 induced stromal keratitis in mice.
    Tamesis RR; Messmer EM; Rice BA; Dutt JE; Foster CS
    Eye (Lond); 1994; 8 ( Pt 3)():298-306. PubMed ID: 7958034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalized toxicity of L-leucyl-leucine-methyl ester for lymphocyte functions.
    Mowat AM; Leck PA
    Immunology; 1990 Apr; 69(4):564-9. PubMed ID: 2335375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+CD25+CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions.
    Sun JB; Cuburu N; Blomquist M; Li BL; Czerkinsky C; Holmgren J
    Scand J Immunol; 2006 Sep; 64(3):251-9. PubMed ID: 16918694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed-type hypersensitivity but normal cytotoxic T lymphocyte and helper T lymphocyte responses.
    Niederkorn JY; Streilein JW
    J Immunol; 1983 Dec; 131(6):2670-4. PubMed ID: 6196396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo activated OVA specific and non-specific CD4+CD25+ regulatory T cells exhibit comparable suppression to OVA mediated T cell responses.
    Li J; Bracht M; Shang X; Radewonuk J; Emmell E; Griswold DE; Li L
    Cell Immunol; 2006 Jun; 241(2):75-84. PubMed ID: 17010326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T lymphocyte function in protein deprived mice.
    Lamont AG; Gordon M; Ferguson A
    Clin Exp Immunol; 1988 Apr; 72(1):113-7. PubMed ID: 3260834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of oral tolerance induction to ovalbumin and enhanced antigen presentation during a graft-versus-host reaction in mice.
    Strobel S; Mowat AM; Ferguson A
    Immunology; 1985 Sep; 56(1):57-64. PubMed ID: 4043996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with mannosylated peptide induces poor T cell effector functions despite enhanced antigen presentation.
    Kel JM; de Geus ED; van Stipdonk MJ; Drijfhout JW; Koning F; Nagelkerken L
    Int Immunol; 2008 Jan; 20(1):117-27. PubMed ID: 18024466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.